April 29, 2023

Katherine Vega Stultz - President and CEO of Ocelot Bio

In this episode of Life Science Success, my guest is Katherine Vega Stultz.  Katherine is the President and CEO of Ocelot Bio, a clinical stage company focused on developing innovative therapeutics to significantly improve outcomes for patients...

In this episode of Life Science Success, my guest is Katherine Vega Stultz.  Katherine is the President and CEO of Ocelot Bio, a clinical stage company focused on developing innovative therapeutics to significantly improve outcomes for patients with end-stage liver disease.

 

In this episode of Life Science Success my guest is Katherine Vega Stultz and we touch upon a number of topics, including the non-linear path of career growth, the importance of being a generalist in a specialized industry, and the challenges and opportunities facing Ocelot Bio, a private venture-backed company that is focused on liver disease. Stultz talks about the importance of team collaboration, transparency, and communication, and how her experiences have helped her develop a continuous improvement mindset. She also discusses her passion for tackling complex problems that impact people's lives and how she is excited to be in a position of leadership that advocates for diversity and talent.

  • Non-linear path of career growth
  • Importance of being a generalist in a specialized industry
  • Challenges and opportunities facing Ocelot Bio
  • Importance of team collaboration, transparency, and communication
  • Continuous improvement mindset
  • Passion for tackling complex problems that impact people's lives
  • Advocacy for diversity and talent in leadership

Please check out our Life Science Success Resources.  You will find tools that will support growing companies and books for authors I have interviewed.  

Katherine Vega Stultz Profile Photo

Katherine Vega Stultz

Chief Executive Officer

Katherine Vega Stultz is a results-driven, entrepreneurial leader with a proven track record building world-class organizations. She brings diverse enterprise leadership experience to her role as CEO of Ocelot Bio with expertise that spans across the entire R&D lifecycle. Katherine has made her mark as a corporate leader at several leading global healthcare companies, growing high-performing teams and building brands that have generated over $1B in annual revenue.

Most recently, Katherine served as chief operating officer at Graphite Bio where she successfully advanced the company’s clinical development program. As the company accelerated its efforts to enter the clinic with its lead investigational gene therapy candidate within its first year of launch, Katherine played a pivotal role in spearheading operational management. Her skill as a team builder was evidenced by the rapid expansion of Graphite’s staff – from a team of 10 to more than 60 in less than one year. Previously, Katherine spent 15 years at Celgene Corporation during a period of exponential growth for the company and its products. Katherine began her career at Eli Lilly & Company and ConvaTec, a Bristol-Myers Squibb company, where she progressed through a series of product development, project management, sales and marketing positions.

Katherine holds a Bachelor of Science degree in Mechanical Engineering (Biomedical Applications) from Cornell University and has attended executive leadership development programs at the Darden School of Business, University of Virginia, IESE Busines… Read More

New to the podcast?

Aug. 11, 2023

Thomas Farb-Horch - CEO of Thrive Bio

This week on the Life Science Success podcast, my guest is Thomas Farb-Horch. Thomas is the CEO of Thrive Bio. He has been involved in the founding of 18 pharmaceutical, biotech, medtech, software, and AI companies, 7 of which have …

Listen to the Episode
Nov. 18, 2023

Cristian Massacesi - Chief Medical Officer & Oncology Chief Developme…

In this episode of Life Science Success, my guest is Cristian Massacesi MD. Cristian is the Chief Medical Officer & Oncology Chief Development Officer at AstraZeneca. In the interview, we will discuss his start in oncology, his career...

Listen to the Episode
March 17, 2024

The Power of GenAI in Life Sciences - Elizabeth Smalley ArisGlobal

This week on Life Science Success, we are thrilled to welcome back Elizabeth Smalley as our guest. Elizabeth is the VP, Product Management, Data & Analytics at ArisGlobal, where she plays a pivotal role in steering the company’s strategic...

Listen to the Episode
April 6, 2024

Dr. Mohit Jain Unveils Next-Gen Tech in Drug Discovery & Therapy

In this episode of Life Science Success, host Don Davis has a conversation with Dr. Mohit Jain, a physician scientist with extensive experience in physiology, biomedicine, and mass spectrometry. Dr. Jain shares his unique journey from clinical...

Listen to the Episode
May 25, 2024

Christiaan Engstrom CEO Bullpen & Bio 2024 Events

In this episode of the Life Science Success Podcast, host Don Davis interviews Christian Engstrom, CEO of Bullpen, an elite club focused on fostering collaborative success in the life sciences industry. They discuss Christian's background, his...

Listen to the Episode
June 29, 2024

Unlocking Precision Cancer Care with Tushar Pandey CEO Symbiosys

Tushar Pandey is a distinguished expert in the Life Sciences industry, currently making significant strides at SimBioSys with his innovative approach to healthcare technology. His contributions have been pivotal in advancing medical solutions and...

Listen to the Episode
June 29, 2024

How William Hind's Belief Continuum is Revolutionizing Pharma Communi…

In this episode of Life Science Success, my guest is William Hind. William, the founder of Alpharmaxim, is transforming how pharma companies communicate their value to healthcare providers. In this episode of Life Science Success, host Don interviews...

Listen to the Episode